Change of Director's Interest Notice - correction
Released
Released
Announcement PDF
ASX Announcement
23 November 2020
Change of Director Interest Notice – Correction
Invion Limited (ASX.IVX) wishes to advise that on 28 October 2020, an Appendix 3Y was lodged for
Thian Chew which contained an incorrect date for the date of change to the interests. The correct
date should have been 22 October 2020. The updated Change of Directors Interest Notice is
attached to this announcement.
Investor enquiries
Thian Chew (Chairman & CEO)
T: +61 3 9692 7222
E: investor@inviongroup.com
Media enquires
Brendon Lau
T: 0409 341 613
E: brendon@vantagepointpartners.com.au
About Invion
Invion is a life-science company that is leading the global research and development of Photosoft™
technology for the treatment of a range of cancers. Invion holds the Australia and New Zealand
license rights to the Photosoft™ technology. Research and clinical trials are funded by the
technology licensor, RMW Cho Group Limited, via an R&D services agreement with the Company.
Invion is listed on ASX (ASX:IVX). This announcement was approved for release by a Sub-Committee
of the Board of Invion Limited. For further information please contact investor@inviongroup.com.
About Photodynamic Therapy (PDT)
Invion is developing Photosoft™ technology as an improved next generation Photodynamic Therapy.
PDT uses non-toxic photosensitisers and visible light in combination with oxygen to produce
cytotoxic-reactive oxygen that kills malignant cells, shuts down tumours and stimulates the immune
system. A potential alternative to surgery, and in contrast to radiotherapy and chemotherapy which
are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins,
and invasion and infiltration of a tumour by leukocytes.
Invion Limited ABN 76 094 730 417
Level 4, 100 Albert Road, South Melbourne, VIC, 3205, Australia
P: +61 9692 7222 W: www.inviongroup.com
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
INVION LIMITED
ABN
76 094 730 417
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Chiat Thian CHEW
Date of last notice
18 February 2019
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Change to direct holding.
Indirect holding is Polar Ventures Limited of
which Thian Chew is director and
beneficiary.
Date of change
22 October 2020
Total No. of securities held prior to change
546,857,721 shares indirectly held.
27,257,615 unlisted share options directly
held
Unlisted Share Options
Class
Number acquired
3,537,736 Share options exercisable at $0.00
each on or before 31 October 2024
(IVXAW).
Number disposed
Nil.
Value/Consideration
Nil
consideration.
Share
Options
issued following Shareholder Approval at
AGM held 21 October 2020.
Note: If consideration is non-cash, provide details and estimated
valuation
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Total No. of securities held after change
546,857,721 shares indirectly held.
30,795,351 Share options
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Share Options issued following Shareholder
Approval at AGM held 21 October 2020.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
n/a
Nature of interest
n/a
Name of registered holder
(if issued securities)
n/a
Date of change
n/a
No. and class of securities to which n/a
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
n/a
Interest disposed
n/a
Value/Consideration
n/a
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
n/a
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No.
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade n/a
to proceed during this period?
If prior written clearance was provided, on what date was this n/a
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Share your feedback
Discover